MARKETS
Strategically Positioned within Growth Markets
TRANSCENDING MARKETS
We leverage our advanced microencapsulation  and enteric coating  technologies to transcend the pharmaceutical landscape.
				            PHASE ONE
We are positioned within the pharmaceutical industry to target well-established and rapidly expanding markets
Set to rapidly gain market share by surpassing current options in effectiveness and ease of use, our initial focus are diabetes, weight control, sexual wellness, and neurocare markets.

With a suite of products already navigating the regulatory approval pipeline, we are poised to set new standards in drug delivery systems, efficacy and patient outcomes.
Diabetes
Diabetes
Global Market Size 1
USD $61.87B
2022
USD $118.00B
2032
Market growth
Growing at a CAGR of 6.67%
$ 28.27B
2028 projected size of U.S. Diabetes market at a CAGR of 3.26% 4
$ 34.46B 2
Size of the global Type 2 Diabetes drug market.
$ 59.45B
By 2031, Type 2 Diabetes growing at a CAGR of 8.20% 3
Weight Loss
Weight Loss
Global Market Size 5
USD $260.70B
2022
USD $532.40B
2032
Market size
US market in 2022 $135.7B
Weight Loss & Diabetes treatments are highly complimentary
Patients are embracing weight loss medication, while insurance companies reluctant to pay. Current medication is inconvenient, painful and very expensive.
Sexual Health
Sexual Wellness
Global Market Size 6
USD $57.50B
2022
USD $110.30B
2030
Market growth
Growing at a CAGR of 8.49%
$4.73B 7
Size of erectile dysfunction market with a CAGR of 8.5% from 2023 to 2030.
Driving factors include rising geriatric population, and a correlation between erectile dysfunction and diseases like diabetes and heart disease.
Neurological Health
Neurocare
Global Market Size 8
USD $5.13B
2022
USD $11.43B
2031
Market growth
Growing at a CAGR of 9.30%
Growth is attributed to the increasing prevalence of migraines.
The COVID-19 pandemic saw an increase in migraine cases, further contributing to demand for migraine medications.
References
(1) Diabetes Drugs Market Size to Worth Around USD 118 BN by 2032 (2) Diabetes Drugs Market Size to Worth Around USD 118 BN by 2032 (3) Type 2 Diabetes Market Size, Share, Growth Analysis (4) United States Diabetes Market Report 2023: A $28.27 Billion Market by 2028 Featuring Braun, Eli Lilly, Terumo, BD, Novo Nordisk, Ypsomed, Medtronic, Insulet, Abbott, DarioHealth, Dexcom, Roche, Tandem (5) Weight Loss Market Size to Hit US$ 532.5 Bn by the end of 2032 (6) Sexual Wellness Market Size to Reach USD 110.33 Billion, Globally, by 2030 at 8.49% CAGR (7) Erectile Dysfunction Market Size, Share, Growth Analysis, By Product(Viagra, Cialis, Zydena, Levitra), By Region - Industry Forecast 2024-203 (8) Migraine Therapeutics Market Size to Surpass US$ 11.43 billion by 2031Interested in finding 
out more?
								                
				                    * For information about our proprietary technology, intellectual property or products.
 
                        Thank You!
Your request has been received!
We will reach out to you shortly.






